COVID-19 not likely passed from moms to babies through breast milk
University of California researchers studying the breast milk of 18 women with COVID-19 found coronavirus RNA—but not live virus—in 1 of 64 samples, suggesting that babies aren't likely to be infected through that route.
The research letter, published yesterday in JAMA, described studying self-collected and mailed samples and clinical data gathered through phone interviews from Mar 27 to May 6. The mothers' babies ranged in age from newborn to 19 months, and each mother provided 1 to 12 breast milk samples.
All but one woman had COVID-19 symptoms. The one sample with coronavirus RNA tested positive only on the day of symptom onset; the ones tested 2 days before and 12 and 41 days later tested negative. The researchers were unable to culture live virus from the positive sample.
To reproduce the conditions of the Holder pasteurization method commonly used to ensure sterilization of human donor milk in banks, the investigators spiked breast milk samples from two different, uninfected donors with the coronavirus. After heating the samples to 62.5°C (144.5°F) for 30 minutes and then cooling them to 4°C (39.2°F), live virus was not found in either sample.
The authors noted that 24 case reports have described the detection of viral RNA in 10 samples from 4 women but cautioned that RNA does not equate with infectiousness; rather, it has to be able to grow and multiply to be transmissible. "These findings are reassuring given the known benefits of breastfeeding and human milk provided through milk banks," they wrote.
In the future, the researchers said they will study whether breast milk from women with COVID-19 contains antibodies that could, in theory, protect their infants from coronavirus infection. Current recommendations to prevent spread of COVID-19 during breastfeeding include handwashing and sterilization of pumping equipment after each use.
Aug 19 JAMA research letter
More teens got routine vaccines in 2019, but doctor orders dropped amid COVID
More US teens received at least one dose of two of the three vaccines recommended for their age-group in 2019 than in 2018, but vaccination orders dropped after the COVID-19 pandemic hit, according to a study by researchers from the Centers for Disease Control and Prevention (CDC) published today in Morbidity and Mortality Weekly Report (MMWR).
The CDC's Advisory Committee on Immunization Practices recommends that 11- and 12-year-old children be vaccinated against pertussis (whooping cough); meningitis (swelling of the membranes covering the brain and spinal cord) types A, C, W, and Y (MenACWY); and human papillomavirus (HPV)-related cancers. Teens 16 years and older are urged to receive a booster dose of the meningococcal vaccine, and those 16 to 23 years old can be vaccinated against meningitis B (MenB), if appropriate.
The researchers found that 71.5% of adolescents received at least one dose of HPV vaccine in 2019, up from 68.1% in 2018. Likewise, the percentage of teens up to date with the two-dose HPV series rose from 51.1% in 2018 to 54.2% in 2019. Rates of vaccination improved in both boys and girls.
The percentage of adolescents vaccinated with at least one dose of MenACWY increased from 86.6% in 2018 to 88.9% in 2019, and more teens began HPV vaccination by the recommended age of 13 years. While the percentage of 17-year-olds receiving the booster dose of MenACWY didn't change significantly over the year, the percentage receiving one or more doses of MenB rose from 17.2% in 2018 to 21.8% in 2019.
Fewer teens living at or above the poverty level outside of a city received at least one dose of HPV and MenACWY vaccines or were up to date on their HPV vaccine series than those living in a city.
When the investigators reviewed Vaccines for Children provider ordering data, they found that vaccine orders for HPV; tetanus, diphtheria, and pertussis (Tdap); and MenACWY dropped in mid-March 2020, after the pandemic arrived. "The COVID-19 pandemic has the potential to offset historically high vaccination coverage with Tdap and MenACWY and to reverse gains made in HPV vaccination coverage," the authors wrote.
Aug 20 MMWR study
Ebola infects 7 more in DRC outbreak; total climbs to 96 cases, 42 deaths
Seven more Ebola cases have been confirmed in the Democratic Republic of the Congo (DRC) outbreak in Equateur province, raising the total to 96, the World Health Organization (WHO) African regional office said on Twitter today.
Also, 5 more deaths were reported, raising the fatality count to 42.
The outbreak has been growing at a slow but steady pace of about one or two cases a day, and it's unclear if the spurt of cases today reflects increased activity or the result of a recent 3-day strike by health workers in the region. The WHO, however, raised concerns about several aspects of the outbreak, including its wide geographic spread and that confirmed case-patients have remained in the community.
The outbreak has been under way since early June and is occurring in the same area where an event in 2018 resulted in 54 cases, 33 of them fatal.
Aug 20 WHO African regional office tweet
CDC warns of 9-state Salmonella outbreak linked to peaches
Late yesterday the CDC announced a new outbreak of Salmonella Enteritidis infections linked to bagged peaches sold at Aldi stores in nine states. Aldi has recalled the fruit from Wawona Packing, LLC.
So far 68 people in nine states have been sickened, and 14 have been hospitalized. There have been no deaths. Illness -onset dates range from Jun 29 to Aug 3, and patients range in age from 1 to 92 years, with a median age of 39.
The bagged peaches were bought at Aldi stores in Connecticut, Illinois, Iowa, Kentucky, Massachusetts, Michigan, Minnesota, New Hampshire, New York, North Dakota, Ohio, Rhode Island, South Dakota, Vermont, West Virginia, and Wisconsin between Jun 1 and Aug 19. Minnesota has the most cases, with 23, followed by Michigan (17) and Iowa and New York (8 each).
"Many ill people report purchasing bagged peaches sold at certain ALDI stores in several states. This investigation is ongoing to identify other retailers that might have sold contaminated peaches," the CDC said.
Aug 19 CDC notice
Global flu still low; CDC updates flu vaccine recommendations
In its latest global flu update that covers the last half of July, the WHO said flu levels are lower than expected for this time of year and noted that COVID-19 activity and response measures may be affecting the usual flu patterns.
Though the Southern Hemisphere's flu season generally runs from May through October, the season hasn't started. Sporadic detections were reported in a few parts of the world, including the Caribbean, Central America, and tropical parts of South America and Africa.
Of about 205,000 flu specimens tested in the last half of July, only 40 were positive for flu, and half were influenza A and half were influenza B. Of the subtyped influenza A viruses, 75% were H3N2.
Aug 17 WHO global flu update
In a related development, the CDC today published in MMWR the latest flu vaccination recommendations for the upcoming season from its Advisory Committee on Immunization Practices (ACIP), which covers updates based on discussions at ACIP's last three meetings.
The CDC has urged all people who are recommended to receive the flu vaccine to be immunized to help reduce symptoms that might be confused with COVID-19 and to reduce the overall burden on the healthcare system over the fall and winter.
The updated recommendations cover two new flu vaccines, both targeted to seniors. One is FluZone high-dose quadrivalent (four-strain), and the other is Fluad Quadrivalent. Other updates include a discussion of using live attenuated influenza vaccine (LAIV) when patients are taking antiviral medications, which might interfere with the actions and effectiveness of the vaccine.
The recommendations note that the newer antivirals peramivir and baloxavir have longer half-lives than other antivirals and could interfere with LAIV replication if given more than 48 hours before vaccination. People who receive LAIV—the nasal spray vaccine—during certain periods may need to be revaccinated with a different type of flu vaccine.
Also, the recommendations for people with egg allergy say that additional measures for people with a history of severe reactions to egg are needed only if a vaccine other than Flucelvax or Flublok are used.
Aug 21 MMWR report